PT825859E - Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool - Google Patents

Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool

Info

Publication number
PT825859E
PT825859E PT96919731T PT96919731T PT825859E PT 825859 E PT825859 E PT 825859E PT 96919731 T PT96919731 T PT 96919731T PT 96919731 T PT96919731 T PT 96919731T PT 825859 E PT825859 E PT 825859E
Authority
PT
Portugal
Prior art keywords
treatment
extracts
forscoline
contain
production
Prior art date
Application number
PT96919731T
Other languages
English (en)
Inventor
Ezio Bompardelli
Paolo Morazzoni
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of PT825859E publication Critical patent/PT825859E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
PT96919731T 1995-05-19 1996-05-09 Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool PT825859E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI951023A IT1275436B (it) 1995-05-19 1995-05-19 Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza

Publications (1)

Publication Number Publication Date
PT825859E true PT825859E (pt) 2002-08-30

Family

ID=11371634

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96919731T PT825859E (pt) 1995-05-19 1996-05-09 Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool

Country Status (18)

Country Link
US (1) US5902823A (pt)
EP (1) EP0825859B1 (pt)
JP (1) JP3001641B2 (pt)
KR (1) KR100423486B1 (pt)
CN (1) CN1099286C (pt)
AT (1) ATE215368T1 (pt)
AU (1) AU697449B2 (pt)
CA (1) CA2221592C (pt)
DE (1) DE69620394T2 (pt)
DK (1) DK0825859T3 (pt)
ES (1) ES2175099T3 (pt)
HK (1) HK1005651A1 (pt)
HU (1) HU223474B1 (pt)
IT (1) IT1275436B (pt)
NO (1) NO316054B1 (pt)
PT (1) PT825859E (pt)
RU (1) RU2183455C2 (pt)
WO (1) WO1996036332A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1001797B9 (en) 1997-07-30 2005-11-23 INDENA S.p.A. Soya extract, process for its preparation and pharmaceutical composition
EP1645272A3 (en) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Daidzin derivatives for the treatment of alcohol dependence or alcohol abuse
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120975A (en) * 1976-08-26 1978-10-17 Fisons Limited Method of psychiatric conditions
US4782082A (en) * 1982-12-27 1988-11-01 Schering Corporation Method for treating allergic reactions with Forskolin
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism

Also Published As

Publication number Publication date
ITMI951023A0 (it) 1995-05-19
AU697449B2 (en) 1998-10-08
JP3001641B2 (ja) 2000-01-24
EP0825859A1 (en) 1998-03-04
ES2175099T3 (es) 2002-11-16
CA2221592A1 (en) 1996-11-21
CN1184422A (zh) 1998-06-10
HUP9801236A2 (hu) 2000-06-28
US5902823A (en) 1999-05-11
CA2221592C (en) 2002-07-09
HUP9801236A3 (en) 2001-09-28
HK1005651A1 (en) 1999-01-22
DK0825859T3 (da) 2002-07-29
DE69620394D1 (de) 2002-05-08
AU5816396A (en) 1996-11-29
WO1996036332A1 (en) 1996-11-21
ATE215368T1 (de) 2002-04-15
EP0825859B1 (en) 2002-04-03
DE69620394T2 (de) 2002-10-02
KR19990014876A (ko) 1999-02-25
KR100423486B1 (ko) 2004-06-05
RU2183455C2 (ru) 2002-06-20
ITMI951023A1 (it) 1996-11-19
NO975155D0 (no) 1997-11-10
NO316054B1 (no) 2003-12-08
IT1275436B (it) 1997-08-07
JPH11500738A (ja) 1999-01-19
NO975155L (no) 1997-11-10
HU223474B1 (hu) 2004-07-28
CN1099286C (zh) 2003-01-22

Similar Documents

Publication Publication Date Title
SE9601421D0 (sv) New composition
NO962108D0 (no) Sigarettfilter
ES2176700T3 (es) Composiciones para la piel.
PT839149E (pt) Derivados da galantamina processo de sua preparacao sua aplicacao como medicamento e as composicoes farmaceuticas que as contem
ES2172600T3 (es) Composicion farmaceutica que comprende lamotrigina.
DE69411726D1 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
PT825859E (pt) Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool
PT1035858E (pt) Utilizacao de extracto de ginkgo biloba para preparar um medicamento
PT1012186E (pt) Utilizacao de produto(s) da proteina kgf e de produto(s) da proteina glp-2 para a preparacao de um medicamento
ATE210435T1 (de) Retinal enthaltendes arzneimittel
ES2096207T3 (es) Prevencion y tratamiento de aterosclerosis.
PT824356E (pt) Composicoes farmaceuticas para o tratamento da dependencia do alcool
AR059965A2 (es) Uso de 8,9-dehidroestrona para la preparacion de un medicamento antioxidante
DE69616591T2 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
AR008474A1 (es) Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
HU214715B (hu) Gyulladáscsökkentő és aranyér kezelésére alkalmas, gyógynövények kivonatát tartalmazó készítmény
GEP19981196B (en) Ointment for Treatment of Keratosis
MX9710478A (es) Utilizacion de un extracto de una bacteria filamentosa no fotosintetica y composicion que la contiene.
NO974687D0 (no) Kondenserte <beta>-carboliner